По вашему запросу найдено документов: 192

Страница 3 из 20

Anticancer Activity of Novel NF-kappa B Inhibitor DHMEQ by Intraperitoneal Administration
Umezawa, K, Breborowicz, A., Gantsev, S. (2020)
therapies for aggressive cancer and leukemia. An NF-kappa B inhibitor named dehydroxymethylepoxyquinomicin
SYNTHESIS AND BIOLOGICAL ACTIVITY OF CYANOETHYL DERIVATIVES OF FUSIDIC ACID
Salimova, E.V., Mamaev, A.G., Tret'yakova, E. V., Kukovinets, O. S., Mavzyutov, A. R., Shvets, K. Yu., Parfenova, L. V. (2018)
INHIBITORS
РЕЗИСТЕНТНОСТЬ К ИНГИБИТОРАМ КОНТРОЛЬНЫХ ТОЧЕК ИММУНИТЕТА В ЛЕЧЕНИИ МЕТАСТАТИЧЕСКОГО РАКА ПОЧКИ
RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF METASTATIC RENAL CANCER
Izmailov, A.A., Rakhimov, R.R., Sultanbayev, A.V., Menshikov, K.V., Gilyazova, I.R., Zabelin, V.M., Izmailov, A.A., Измайлов, А.А., Рахимов, Р.Р., Султанбаев, А.В., Меньшиков, К.В., Гилязова, И.Р., Забелин, В.М., Измайлов, А.А. (2023)
RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF METASTATIC RENAL CANCER
Exosomal miRNA-146a and miRNA-424 as Possible Predictors of Immune Checkpoint Inhibitors Therapy Response in Clear Cell Renal Cell Carcinoma
Asadullina, D.D., Gilyazova, I.R., Ivanova, E.A., Izmailova, S.M., Gilyazova, G.R., Pavlov, V.N., Khusnutdinova, E.K. (2024)
inhibitors (ICI) still have limited therapeutic efficacy. A growing number of investigations has demonstrated
Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
Ivanova, Elizaveta, Asadullina, Dilara, Gilyazova, Gulshat, Rakhimov, Radmir, Izmailov, Adel, Pavlov, Valentin, Khusnutdinova, Elza, Gilyazova, Irina (2023)
Immunotherapy with immune checkpoint inhibitors (ICIs) has shown high efficiency in clear cell
Новые аспекты в механизмах ишемического и реперфузионного повреждения миокарда
Novel Aspects of Cardiac Ischemia and Reperfusion Injury Mechanisms
Т. А. Ягудин, T. A. Yagudin, А. Т. Шабанова, A. t Shabanova, Хонг-Ю Лиу, Hong-Yu Liu (Креативная хирургия и онкология, №3, 2019)
Механизм работы разных поколений ингибиторов EGFR при злокачественных опухолях легких. Обзор литературы и обобщение данных
The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis
Насретдинов, А.Ф., Меньшиков, К.В., Султанбаев, А.В., Мусин, Ш.И., Султанбаева, Н.И., Меньшикова, И.А., Nasretdinov, A.F., Menshikov, K.V., A.V., Sultanbaev, Musin, Sh.I., Sultanbaeva, N.I., Men'shikova, I.A. (2022)
The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors
Enhancers of mesenchymal stem cell stemness and therapeutic potency
Al-Azab, Mahmoud, Idiiatullina, Elina, Safi, Mohammed, Hezam, Kamal (2023)
mTOR Inhibitors
БИОМАТЕРИАЛ "АЛЛОПЛАНТ" КАК ИНГИБИТОР РУБЦЕВАНИЯ ПОВРЕЖДЕННОЙ РОГОВИЦЫ (ИММУНОГИСТОХИМИЧЕСКОЕ ИССЛЕДОВАНИЕ)
"ALLOPLANT" BIOMATERIAL AS THE INHIBITOR OF SCARRING THE DAMAGED CORNEA (IMMUNOCHISTOCHEMICAL STUDY)
МУСИНА, Л.А., ШАКИРОВ, Р.Ф., ГАЛИМОВА, В.У., ШАНГИНА, О.Р., ЛЕБЕДЕВА, А.И., КАДЫРОВ, Р.З., Musina, L.A., Shakirov, R.F., Galimova, V.U., Shangina, O.R., Lebedeva, A.I., Kadirov, R.Z. (2019)
"ALLOPLANT" BIOMATERIAL AS THE INHIBITOR OF SCARRING THE DAMAGED CORNEA (IMMUNOCHISTOCHEMICAL STUDY)
Clinical and Genetic Characteristics of Calvarial Doughnut Lesions with Bone Fragility in Three Families with a Reccurent SGMS2 Gene Variant
Elena, Merkuryeva, Tatiana, Markova, Anton, Tyurin, Diana, Valeeva, Vladimir, Kenis, Maria, Sumina, Igor, Sorokin, Olga, Shchagina, Mikhail, Skoblov, Maria, Nefedova, Rita, Khusainova, Ekaterina, Zakharova, Dadali, Elena, Kutsev, Sergey (2023)
of which is sphingomyelin synthase 2, which primarily contributes to sphingomyelin (SM) synthesis—the main

Страница 3 из 20

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год